Matching placebo to sitagliptin
Sponsors
Merck Sharp & Dohme LLC
Conditions
Type 2 Diabetes Mellitus
Phase 3
A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
CompletedNCT00541450
Start: 2008-01-15End: 2010-01-16Updated: 2017-05-12
MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
CompletedNCT00722371
Start: 2008-09-05End: 2011-03-25Updated: 2017-05-12
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
CompletedNCT02532855
Start: 2015-10-20End: 2017-10-10Updated: 2018-11-20